PLEASANTON, Calif., June 5, 2023 /PRNewswire/ -- As the industry advances clinical operations, adopting applications on a unified platform is a top priority to increase study efficiency and compliance. More than 450 biopharma companies-including 18 of the top 20 pharmas and 4 of the top 6 CROs-use veeva vault etmf to automate trial processes and improve information exchange across stakeholders.

As regulatory and trial complexity grows, more companies are increasing transparency and inspection readiness with Vault eTMF. veeva systems (NYSE: veev ) is helping organizations address critical TMF challenges with innovations, including:

• tmf bot to automate document classification for faster, more efficient processing and improved accuracy. TMF Bot has classified more than one million documents, saving customers tens of thousands of hours in processing time.
• seamless connection between vault etmf and veeva vault rim to increase efficiency and collaboration between clinical and regulatory teams. Customers have shared more than 40,000 documents across more than 600 studies.
• tmf transfer to enable the quick exchange of TMF documents between sponsors and CROs. This has eliminated hundreds of hours in manual end-of-study migrations.
• veeva site connect to streamline information exchange with research sites. Customers have exchanged more than 100,000 documents across more than 1,000 connected study sites.

"We're excited to continue partnering with customers to advance TMF for more efficient, compliant clinical trials," said Jason Methia, vice president, Veeva Vault Clinical Operations strategy. "By delivering Veeva Vault eTMF innovations, we're tackling challenges that can significantly streamline study processes and move the industry forward."

Vault eTMF is part of veeva vault clinical suite , the industry's first cloud platform that unifies clinical data management and operations. Vault Clinical Suite includes Vault eTMF, vault ctms , veeva site connect , vault payments , vault study start-up , vault study training , vault edc , veeva cdb , veeva rtsm , and veeva epro .

Additional Information
For more on Veeva Vault eTMF, visit: veeva.com/etmf
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems
Veeva
is
the
global
leader
in
cloud
software
for
the
life
sciences
industry.
Committed
to
innovation, product
excellence,
and
customer success,
Veeva
serves
more
than
1,000
customers,
ranging
from the world's
largest
biopharmaceutical
companies
to
emerging
biotechs.
As a
public
benefit
corporation,
Veeva
is
committed
to
balancing
the
interests
of
all
stakeholders,
including
customers, employees,
shareholders,
and
the
industries
it
serves.
For more
information,
visit
veeva.com.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's
products
and services and the expected
results
or benefits from use of our
products
and services. These statements are based on our current expectations. Actual
results
could differ materially from those provided in this release and we have no obligation to
update
such statements. There are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2023, which you can find
here
(a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at
sec.gov .

SOURCE Veeva Systems

MENAFN05062023003732001241ID1106388187